Key result
Iron-adriamycin complexes mediate the reduction of O2 through a cycle of iron-catalyzed electron transfer, which may explain adriamycin's antitumor potency and toxic side effects.
Population
In vitro chemical system of Fe2+- and Fe3+-adriamycin complexes
Comparison
Addition of O2 vs Anaerobic conditions
Design
Preclinical
Authors
Loading...
May inform anthracycline redox mechanisms; leaves open clinical relevance to cardiotoxicity.
Demonstrates that iron-adriamycin complexes mediate the reduction of O2, providing a potential biochemical mechanism for adriamycin's antitumor efficacy and toxicity.
Jay L. Zweíer (1984) studied this question. Iron-adriamycin complex was evaluated on Electron paramagnetic resonance (EPR) spectra and O2 reduction. Iron-adriamycin complexes mediate the reduction of O2 through a cycle of iron-catalyzed electron transfer, which may explain adriamycin's antitumor potency and toxic side effects.
Synapse has enriched one closely related paper. Consider it for comparative context: